![](https://monteverdelaw.com/wp-content/uploads/case-logo/aerie-pharmaceuticals-inc.png)
Aerie Pharmaceuticals, Inc. (AERI), relating to its proposed acquisition by Alcon Inc. Under the terms of the agreement, AERI shareholders are expected to receive $15.25 in cash per share they own.
Aerie Pharmaceuticals, Inc. (AERI), relating to its proposed acquisition by Alcon Inc. Under the terms of the agreement, AERI shareholders are expected to receive $15.25 in cash per share they own.